Pharmacogenomics in clinical dermatology
Genetic testing based on the detection of polymorphisms related to the metabolism of the most commonly prescribed drugs used in the 10 most relevant clinical dermatological conditions, such as psoriasis, acne, dermatitis, rosacea, among others, in order to provide the patient with an accurate, safe, and effective treatment.
What does the OmiGenomics Pharmacogenomics in clinical dermatology kit include?
What does Omigenomics comprehensive service include?
Epigenetics in cosmetic dermatology
This assay detects the skin’s current physiological state through epigenetic markers/factors related to aging (photoaging, antioxidant capacity, and firmness/elasticity) and skin quality (moisture retention, regenerative capacity, and pigmentation), parameters that are affected by a patient’s environment and lifestyle.